Indivior (INDV)
(Real Time Quote from BATS)
$13.11 USD
-0.46 (-3.39%)
Updated Aug 5, 2024 12:30 PM ET
5-Strong Sell of 5 5
D Value D Growth D Momentum D VGM
Indivior PLC (INDV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$23.67 | $25.00 | $22.00 | 74.43% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Indivior PLC comes to $23.67. The forecasts range from a low of $22.00 to a high of $25.00. The average price target represents an increase of 74.43% from the last closing price of $13.57.
Analyst Price Targets (3 )
Broker Rating
Indivior PLC currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on four recommendations.
Of the five recommendations deriving the current ABR, five are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/23/2024 | Piper Sandler | David Amsellem | Strong Buy | Strong Buy |
7/10/2024 | Craig-Hallum | Chase Knickerbocker | Strong Buy | Strong Buy |
7/9/2024 | Northland Capital Markets | Carl Byrnes | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 5 |
Average Target Price | $23.67 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 154 of 253 |
Current Quarter EPS Est: | 0.44 |